| # | Drug | Count |
|---|---|---|
| 0 | METFORMIN | 22 |
| 1 | METHOTREXATE | 16 |
| 2 | METHOTREXATE SODIUM | 16 |
| 3 | VINCRISTINE SULFATE | 15 |
| 4 | DEXAMETHASONE | 13 |
| 5 | DEXAMETHASONE 1.5 MG | 13 |
| 6 | METFORMIN ER 500 MG | 13 |
| 7 | METFORMIN ER 750 MG | 13 |
| 8 | CYCLOPHOSPHAMIDE | 12 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS | 1 | 0.0109 |
| 1 | RELACORILANT | 1 | 0.0101 |
| 2 | SODIUM NITROPRUSSIDE | 1 | 0.0026 |
| 3 | PHENOBARBITAL SODIUM | 1 | 0.0024 |
| 4 | SODIUM THIOSULFATE | 1 | 0.0018 |
| 5 | TEBENTAFUSP | 1 | 0.0017 |
| 6 | CALASPARGASE PEGOL | 1 | 0.0012 |
| 7 | SALSALATE | 1 | 0.0011 |
| 8 | MITOXANTRONE HYDROCHLORIDE | 6 | 0.0010 |
| 9 | BREXUCABTAGENE AUTOLEUCEL | 2 | 0.0009 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 1 | 0.0017 |
| 1 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 1 | 0.0006 |
| 2 | Selective T Cell Costimulation Blocker [EPC] | 2 | 0.0004 |
| 3 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 5 | 0.0004 |
| 4 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 5 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 6 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 7 | Asparagine-specific Enzyme [EPC] | 3 | 0.0002 |
| 8 | Antifibrinolytic Agent [EPC] | 2 | 0.0002 |
| 9 | CD19-directed Chimeric Antigen Receptor [EPC] | 2 | 0.0002 |